TG Therapeutics Inc annual earnings per share (EPS) for fiscal TTM was $2.74, a decrease of 1.1% from $2.77 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $2.74 | $2.77 | $0.15 | $0.09 | $-1.65 | $-2.63 | $-2.42 | $-1.96 | $-2.30 | $-1.91 | $-1.60 | $-1.38 | $-1.64 | $-0.81 | $-1.38 | $-0.44 | $15.68 | $-111.24 | $-170.00 | $-497.55 | $-453.62 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $0.05 | $0.12 | $0.14 | $2.43 | $0.17 | $0.03 | $0.15 | $0.02 | $0.04 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More TGTX metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All TGTX financial statements → Interactive TGTX charts →
About TickerBase · Data methodology & sources · Privacy · Terms